IDO1 contributes to the immunosuppression of the tumor microenvironment [15], and elevated levels of IDO1 have been correlated to shorter survival in ovarian and endometrial cancers, as well as UC [16–18]. This evidence concerns the gene IDO1 and endometrial cancer.